https://doi.org/10.1016/j.ekir.2019.03.016
A
Alexander R. Cobitz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
2.4K
Citations
25
h-index
40
i10-index
Alexander R. Cobitz is an academic researcher. The author has contributed to research in topics: Erythropoietin and Anemia Treatment & Dialysis and Renal Disease Management & Hemoglobinopathies and Related Disorders. The author has an h-index of 25, co-authored 73 publications.
Papers by this author
worksCardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions—A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)
2019 · Kidney International Reports · 46 citations
Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients
2015 · BMC Nephrology · 44 citations
https://doi.org/10.1186/s12882-015-0138-x
GlaxoSmithKline responds to the consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
2009 · Diabetologia · 2 citations
https://doi.org/10.1007/s00125-009-1301-3
PowerPoint Slides for: Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.4488194.v1
Supplementary Material for: Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.4476137.v1
Supplementary Material for: Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13795589
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat